Rixa Health Review
Best for: Patients wanting a functional-medicine telehealth practice with bundled compounded GLP-1 pricing
Rixa Health is a direct-to-consumer functional-medicine telehealth practice prescribing compounded and oral semaglutide and tirzepatide (plus other peptides) for weight loss via partner US pharmacies. Board-certified DO and FNP providers take a root-cause approach with required monthly follow-ups for the first six months. Weight-loss medication is bundled with visits into one price, with no charge until after approval. Cash-pay only; available in nearly all states, a few coming soon. Compounded, not branded, GLP-1 is the focus.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Rixa Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Rixa Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Functional-medicine, root-cause clinical approach
- •Compounded and oral semaglutide plus tirzepatide offered
- •Board-certified DO and FNP providers with years of experience
- •Medication bundled with visits into a single price
- •No charge until after approval
- •Required monthly follow-ups support adherence and safety
- •Available in nearly all US states
✗ Cons
- •No public monthly pricing; quoted only during consultation
- •Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- •A handful of states still listed as coming soon
- •Branded GLP-1 medications are not the primary offering
- •Requires ongoing monthly follow-up commitment
Ready to start with Rixa Health?
See current pricing and start your free consultation.
Sources & methodology
Our Rixa Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Rixa Health
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Rixa Health?
See current pricing and start your free consultation.